Today is World Osteoporosis Day!

To mark World Osteoporosis Day, we are thrilled to share three insightful scientific publications that delve into Trabecular Bone Score (TBS) and its pivotal role in detecting, managing and treating bone fragility and osteoporosis.

These publications demonstrate the broad adoption of TBS internationally, and how it has been used in occupational settings, classifying patients ahead of surgery and identifying comparative treatment effects for postmenopausal women, amongst other cutting-edge areas of osteoporosis research.

Medimaps Group is joining the International Osteoporosis Foundation (IOF) to #StepUpForBoneHealth. Preventing fractures is at the center of osteoporosis management, this is why Trabecular Bone Score (TBS) plays a crucial role in the clinical management of osteoporosis patients.

Together, let us empower individuals with the knowledge and identification tools to combat osteoporosis, individualize treatments and promoting healthier, stronger bones for all. Happy reading!

In 60 to 90 year old Japanese patients with and without vertebral fractures, the Trabecular Bone Score was significantly lower in patients with a vertebral fracture, and was also a significant risk factor for vertebral fractures.

Osteoporosis using WHO BMD criteria was identified in 9.6% of candidates for spine fusion surgery and aged over 50, and osteopenia in 34.6% of patients. Almost 70% of those with osteopenia had degraded or partially degraded bone microarchitecture. The addition of TBS to BMD indicated that 33.7% of patients had poor bone quality.

This study examined vertebral fractures (VF), BMD and TBS in an occupational cohort. Over one-third (34.7%) had vertebral fractures, and both TBS and BMD predicted VFs. Using both BMD and TBS together best predicted VF.